STEVENSON, Md., March 13, 2018 -- The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of Massachusetts on behalf of purchasers of Tesaro Incorporated (Nasdaq:TSRO) (“Tesaro” or the “Company”) securities during the period between March 14, 2016 and January 12, 2018, inclusive (the “Class Period”). Investors who wish to become proactively involved in the litigation have until March 19, 2018 to seek appointment as lead plaintiff.
If you wish to choose counsel to represent you and the class, you must apply to be appointed lead plaintiff and be selected by the Court. The lead plaintiff will direct the litigation and participate in important decisions including whether to accept a settlement for the class in the action. The lead plaintiff will be selected from among applicants claiming the largest loss from investment in Tesaro securities during the Class Period. Members of the class will be represented by the lead plaintiff and counsel chosen by the lead plaintiff. No class has yet been certified in the above action.
The complaint accuses the defendants of violations of the Securities Exchange Act of 1934 by virtue of the defendants’ failure to disclose during the Class Period that substantial undisclosed health risks, including anaphylaxis and anaphylactic shock, were associated with Tesaro’s intravenous formulation of Varubi.
According to the complaint, following a January 12, 2018 announcement that Tesaro had updated the U.S. labeling for the intravenous formulation of Varubi and that it had issued a “Dear Healthcare Professional” letter, the value of Tesaro shares declined significantly.
If you have suffered a loss in excess of $100,000 from investment in Tesaro securities purchased on or after March 14, 2016 and held through the revelation of negative information during and/or at the end of the Class Period and would like to learn more about this lawsuit and your ability to participate as a lead plaintiff, without cost or obligation to you, please contact Brower Piven either by email at [email protected] or by telephone at (410) 415-6616.
Attorneys at Brower Piven have extensive experience in litigating securities and other class action cases and have been advocating for the rights of shareholders since the 1980s. If you choose to retain counsel, you may retain Brower Piven without financial obligation or cost to you, or you may retain other counsel of your choice. You need take no action at this time to be a member of the class.
CONTACT: Charles J. Piven
Brower Piven, A Professional Corporation
1925 Old Valley Road
Stevenson, Maryland 21153
Telephone: 410-415-6616
[email protected]


AST SpaceMobile Joins MSCI ACWI Index as Largest New Addition, Boosting Market Visibility
Alphabet Plans Rare 100-Year Sterling Bond to Fund AI Expansion
xAI Co-Founder Jimmy Ba Departs as Elon Musk’s AI Startup Faces Turbulence
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible
Ancora Holdings Builds $200M Stake in Warner Bros Discovery, Targets Netflix Asset Sale Plan
FDA Rejects Review of Moderna’s Flu Vaccine Application, Shares Slide
Trump Administration Plans Chip Tariff Exemptions for Big Tech Amid AI Data Center Push
Lyft Shares Slide After Weak Q1 Profit Forecast and Surprise 2025 Operating Loss
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Samsung Electronics Shares Jump on HBM4 Mass Production Report
Samsung Electronics Sees Sustained AI-Driven Demand for Memory Chips Into Next Year
Russia Signals Further Restrictions on Telegram Amid Ongoing Regulatory Disputes
Standard Chartered Names Peter Burrill as Interim Group CFO Following Diego De Giorgi’s Exit
FAA Confirms $1.5 Billion Peraton Contract as U.S. Air Traffic Control Overhaul Accelerates
SMIC Shares Slide Despite Strong AI-Driven Earnings as Margin Pressure Looms
Cloudflare Forecasts Strong Revenue Growth as AI Fuels Cloud Services Demand
Ralph Lauren Unveils Elegant Fall 2026 Women’s Collection Ahead of New York Fashion Week 



